Ai-based Digital Pathology: Ai-based Pathology Transforming Disease Diagnosis

By Author: colin
Total Articles: 197
Comment this article

The field of pathology relies on the microscopic examination of biological tissue samples by trained pathologists to diagnose diseases. Traditionally, this process involves staining glass slides with tissue sections and analyzing them under a microscope. However, this manual workflow can be labor-intensive, time-consuming and vulnerable to human errors. Digital pathology aims to address these challenges by digitizing whole glass slide images and analyzing them using computational techniques. This emerging technology has the potential to revolutionize disease diagnosis and medical research.

Digitizing AI-Based Digital Pathology

The first step in digital pathology involves digitizing glass slides containing tissue sections into high-resolution whole slide images (WSIs). Specialized digital slide scanners are used to optically scan the glass slides at high magnifications (up to 40X-400X) and multiple color channels. This process produces gigantic image files, sometimes exceeding 100 gigapixels in size for a single slide. AI-Based Digital Pathology scanned images are then stored as multi-tiered digital ...
... images that maintain the spatial relationships between cells, tissues and diagnostic details. Being in digital form, the WSIs can be analyzed by computers and shared over networks. Several pathology labs have now digitized their archives of millions of glass slides using this technique.

Leveraging AI For Automated Analysis

With large collections of digitized slides, the next frontier is to develop artificial intelligence (AI) algorithms that can automatically analyze them to assist pathologists. Deep learning models, in particular convolutional neural networks, have shown success in tasks like medical image analysis. Researchers are actively working on training neural networks using huge datasets of digital slides with annotated disease regions, cell types and pathologies. The goal is to develop AI systems that can help identify areas of diagnostic significance, extract quantitative imaging features, detect rare cells/structures and even suggest preliminary diagnoses. Some promising applications include automated scanning of whole slides, cancer grading, metastases detection and prognosis prediction. Such AI tools have the potential to increase diagnostic accuracy, consistency and throughput for pathologists.

Challenges In Training Models

However, developing accurate AI models for digital pathology poses unique technical challenges compared to general medical image analysis tasks:

- Scarcity of annotated datasets: Manually annotating regions/features in whole slide images is an extremely labor-intensive process. Very few public datasets with detailed pathological annotations exist.

- Scale of gigapixel images: Training deep learning models on images exceeding 100,000 x 100,000 pixels requires specialized computing infrastructure and algorithms to handle such massive volumes of data.

 
- Variability in tissue morphology: Differences in staining protocols, tissue preservation methods etc. across labs and patients can affect model generalization capabilities.

- Interpretability concerns: Pathologists need confidence that AI diagnoses are based on established pathological criteria rather than unintelligible patterns. Researchers focus on explainable machine learning techniques.

- Regulatory and clinical validation hurdles: Demonstrating equivalency to human diagnostic performance through rigorous prospective studies is necessary before deployment in patient care settings.

Overcoming such barriers will require sustained research efforts pairing machine learning scientists and computational pathologists. Standardized benchmark datasets and metrics are also needed to objectively evaluate model performance.

Early Applications In The Clinic

While fully automated diagnostic models may be a few years away, some initial AI applications for digital pathology are gradually making their way into clinical usage:

- Triage of patients based on AI-detected prognostic or predictive biomarkers. This helps pathologists prioritize time-critical cases.

- Computer-aided detection of rare microscope magnified structures in WSIs to reduce human oversight errors.

- Automatic quantification of immunohistochemistry (IHC) stained slides to grade tumor characteristics objectively.

- Centralized telepathology services leveraging AI to deliver expert sub-specialty opinions to remote locations.

As regulatory oversight accommodates real-world evidence and incremental validation approaches, AI-based digital pathology tools have the potential to transform disease screening programs and precision oncology initiatives worldwide in this new decade. With continued cross-disciplinary collaboration, this disruptive technology is poised to elevate cancer diagnosis and patient care to new heights in the coming years.

AI and digital pathology form a promising combination that can help address some of the limitations of traditional microscopy-based examination. While overcoming technical hurdles, early applications demonstrate the ability to augment pathologists' workflow. With further research and validation, AI-empowered digital pathology holds great potential to standardize diagnosis, enable remote consultations and accelerate medical discoveries at a global scale.

Get more insights on this topic: https://heyjinni.com/read-blog/132913

Author Bio

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups. (LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it